Short naps sharpened alertness. Long habitual naps tracked with worse outcomes.

The largest synthesis of the question splits the answer by duration. Across 44 cohort studies covering 1,864,274 people, habitual napping of 30 minutes or longer was associated with a higher risk of all-cause mortality, cardiovascular disease and metabolic disease — while people whose naps ran under 30 minutes showed no significant excess risk on those outcomes [s1]. Separately, in controlled short-term studies, a daytime nap improved cognitive performance, with the clearest gain in alertness [s2].

"Are naps good for you" turns out to be two questions wearing one coat: what a nap does to you this afternoon, and what a habit of napping says about your health over years.

The long-run observational picture

The cohort meta-analysis searched PubMed, Web of Science, Embase and the Cochrane Library from inception to 9 March 2024, and pooled 44 cohort studies of participants aged 20 to 86, with a mean age of 56.4 years [s1].

Overall, habitual napping was associated with increased risk of several adverse outcomes — all-cause mortality, cardiovascular disease, metabolic disease and cancer — and with decreased risk of two others: cognitive impairment and sarcopenia [s1].

The duration threshold is where the analysis earns its keep. Individuals napping for 30 minutes or longer showed higher risk of all-cause mortality, cardiovascular disease and metabolic disease, whereas those napping less than 30 minutes had no significant risks on those outcomes [s1]. No significant differences emerged for napping frequency, the percentage of nappers in a study, sample size, sex, age, body mass index, follow-up duration, or comorbidity status [s1].

The authors' own recommendation is that individuals with a long napping duration should consider shortening their daily nap to 30 minutes or less [s1].

The confounding problem this design cannot solve

Every one of those 44 studies is a cohort study, which means napping was observed rather than assigned [s1]. That leaves the central alternative explanation untouched: people nap for longer when they are unwell, and unwellness is what produces the mortality, cardiovascular and metabolic outcomes being counted.

Undiagnosed sleep-disordered breathing, depression, chronic pain and early neurodegeneration all plausibly cause both long daytime naps and bad long-term outcomes. A cohort design records the nap and the outcome, not the thing that may have caused both.

The mixed direction of the findings is itself a hint. If long naps were straightforwardly harmful, it would be odd for habitual napping to be associated with lower risk of cognitive impairment and sarcopenia in the same analysis [s1]. A marker of underlying illness, rather than a cause of it, would be expected to produce exactly this kind of inconsistent pattern.

The short-run experimental picture

The other literature is smaller, cleaner and answers a different question. A systematic review and meta-analysis of the immediate cognitive effects of a daytime nap pooled 11 studies with 381 working-aged participants, with a mean nap duration of 55.4 ± 29.4 minutes [s2]. All 11 were conducted in laboratory conditions, one of them including a subgroup studied in working conditions [s2].

Cognitive performance did not differ between groups at baseline (effect size −0.03, 95% CI −0.14 to 0.07), and improved in the nap group after the nap (0.18, 95% CI 0.09 to 0.27), with the strongest effect on alertness (0.29, 95% CI 0.10 to 0.48) [s2]. Sensitivity analyses restricted to randomised controlled trials, and analyses excluding outliers, gave similar results [s2].

Performance mainly improved for up to 120 minutes after the nap, with conflicting findings during the sleep inertia period immediately on waking [s2]. Naps taken earlier in the afternoon, before 1:00 p.m., were associated with better cognitive performance (0.24, 95% CI −0.07 to 0.34) — though that interval crosses zero, which means the timing finding is weaker than the direction of the estimate suggests [s2]. The benefits were independent of sex and age, and neither the duration of the nap nor the interval between the nap and testing influenced cognitive performance [s2].

The authors close by noting that their analyses were almost entirely laboratory-based, and that more studies in real working conditions are needed before daytime napping could be implemented at work as a measure to improve efficiency [s2].

What the two literatures jointly support

That a nap can improve alertness in the hours after it, on evidence from small controlled studies in laboratory settings [s2]. That habitual long napping travels with worse cardiovascular, metabolic and mortality outcomes across a very large observational dataset, with the risk concentrated above about 30 minutes [s1]. And that the second of those findings cannot, by the design of the studies that produced it, tell a reader whether shortening their naps would change anything.

The one place the two literatures come close to agreeing is on duration: the observational risk signal begins at 30 minutes [s1], and the experimental benefit did not depend on nap length at all [s2]. Nothing in either dataset suggests that a longer nap buys more alertness.

This article describes what the studies found. It is not medical advice, and persistent daytime sleepiness — the reason many people nap in the first place — is a symptom that belongs in front of a clinician rather than a stopwatch.

Sources

• To nap or not? Evidence from a meta-analysis of cohort studies of habitual daytime napping and health outcomes — Sleep Medicine Reviews, 2024-08-07
• Effects of a Short Daytime Nap on the Cognitive Performance: A Systematic Review and Meta-Analysis — International Journal of Environmental Research and Public Health, 2021-09-28